FDA Inspection 1286354 — Albemarle US, Inc.
The FDA completed an inspection of Albemarle US, Inc. on Sep 8, 2025 in Kings Mountain, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 8, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Kings Mountain, NC (United States)